We are live on ! Find out more
INMB icon

INmune Bio
INMB

33 hedge funds and large institutions have $15.5M invested in INmune Bio in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

27% more funds holding

Funds holding: 26 → 33 (+7)

2.4% more ownership

Funds ownership: 6.35% → 8.75% (+2.4%)

3% more capital invested

Capital invested by funds: $15M → $15.5M (+$515K)

Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.09M
3
Millennium Management
Millennium Management
New York
+$756K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$595K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$489K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$246K
2
DC
Diametric Capital
Massachusetts
-$215K
3
VNA
Valley National Advisers
Pennsylvania
-$34K
4
CAAS
Capital Asset Advisory Services
Michigan
-$32K
5
Barclays
Barclays
United Kingdom
-$20.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.72M +$1.09M +60,289 +24%
IC
2
Ikarian Capital
Texas
$2.77M +$288K +16,008 +7%
BlackRock
3
BlackRock
New York
$2.61M +$3.57M +198,487 +934%
Deutsche Bank
4
Deutsche Bank
Germany
$1.26M +$180K +10,000 +10%
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$779K +$154K +8,550 +15%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$722K +$489K +27,182 +81%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$536K -$246K -13,682 -23%
Millennium Management
8
Millennium Management
New York
$499K +$756K +41,988 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$393K +$595K +33,072 New
BFM
10
Boothbay Fund Management
New York
$381K +$160K +8,909 +38%
HF
11
HRT Financial
New York
$262K +$397K +22,055 New
FAIM
12
Financial Advocates Investment Management
Washington
$234K +$27K +1,500 +8%
ECM
13
ExodusPoint Capital Management
New York
$203K +$307K +17,073 New
Northern Trust
14
Northern Trust
Illinois
$166K +$28.4K +1,575 +13%
SFI
15
Susquehanna Fundamental Investments
Pennsylvania
$162K +$2.32K +129 +1%
TRCT
16
Tower Research Capital (TRC)
New York
$159K +$241K +13,365 New
Jane Street
17
Jane Street
New York
$145K +$220K +12,221 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$131K – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$94K +$35.7K +1,982 +33%
FIA
20
FNY Investment Advisers
New York
$73K +$32.4K +1,800 +41%
UBS Group
21
UBS Group
Switzerland
$39K +$55.1K +3,059 +1,224%
Morgan Stanley
22
Morgan Stanley
New York
$37K +$27.5K +1,526 +97%
Citigroup
23
Citigroup
New York
$23K +$34.3K +1,908 New
Barclays
24
Barclays
United Kingdom
$20K -$20.6K -1,146 -41%
Bank of America
25
Bank of America
North Carolina
$20K – – –
1
2

INMB Hedge Fund Activity: Q1 2021 in Review

33 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q1 2021, worth a combined $15.5M — up 3.4% from $15M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new INMB positions and 3 closed out — a net gain of 7 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $3.57M. The largest seller was Bank of Montreal, cutting an estimated $246K.

  • 33 institutional investors held INmune Bio (INMB) as of Q1 2021, up from 26 in Q4 2020.
  • Funds reported $15.5M of INmune Bio stock for Q1 2021, up 3.4% quarter-over-quarter.
  • 10 funds opened new INmune Bio positions in Q1 2021 and 3 closed out, a net change of +7 holders.
  • The largest INmune Bio buyer in Q1 2021 was BlackRock, an estimated $3.57M added.
  • The largest INmune Bio seller in Q1 2021 was Bank of Montreal, an estimated $246K sold.

Based on aggregated 13F filings for Q1 2021.